1. Doxil®—the first FDA-approved nano-drug: from an idea to a product;Barenholz,2012
2. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers;Gabizon;Cancer Res.,1983
3. Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model;Gabizon;Br. J. Cancer,1985
4. Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration;Gabizon;J. Natl. Cancer Inst.,1986
5. Design, characterization and anti-tumor activity of adriamycin-containing phospholipid vesicles;Gabizon,1986